ArticleHuman vaccines & immunotherapeutics2022

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees.

Francesca Dapporto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.